TNFSF4 and melanoma: IL2 is targeted in immunotherapy, particularly in the treatment of certain cancers like melanoma and renal cell carcinoma44; the immune genes TNFSF4, important in T cell activation45, have been proposed as immunotherapy targets, and GNLY, important in NK cell biology, is a diagnostic marker and have potential as immunotherapy target46